Summit Therapeutics Inc. (SMMT) Form 424B5 — Jun 9, 2026
Summit Therapeutics Inc. is offering $500 million of common stock in a prospectus supplement dated June 9, 2026, with an assumed public offering price of $14.11 per share. This offering represents approximately 4.6% of the company's current outstanding shares, resulting in immediate dilution for existing shareholders. The capital raise is driven by a disclosed going-concern risk, as the company stated it does not have sufficient working capital to fund planned operations for the next twelve months without additional funding.
Key figures
- Greenshoe
- 75000000
- Gross Proceeds
- 500000000
- Offering Price
- 14.11
- Shares Offered
- 35435861
- Shares Outstanding
- 776017474
- Atm Program Remaining
- 276200000
- Total Net Tangible Book Value
- 544000000
- Net Tangible Book Value Per Share
- 0.7
Price after filing
Close on the filing date to close N calendar days later (from $14.29). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.